These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1372425)

  • 1. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of serum procainamide and N-acetylprocainamide: a comparison of emit and reverse-phase high-performance liquid chromatography.
    Griffiths WC; Dextraze P; Hayes M; Mitchell J; Diamond I
    Clin Toxicol; 1980 Mar; 16(1):51-4. PubMed ID: 6156051
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of the EMIT procainamide and N-acetylprocainamide assay.
    Walberg CB; Wan SH
    Ther Drug Monit; 1979; 1(1):47-56. PubMed ID: 95422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
    Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved liquid chromatographic determination of procainamide and N-acetylprocainamide in serum.
    Patel CP
    Ther Drug Monit; 1983 Jun; 5(2):235-8. PubMed ID: 6192559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluorescence polarization immunoassay with liquid chromatography for quantification of procainamide and N-acetylprocainamide in urine.
    Tisdale JE; Padhi ID; Ware JA; Svensson CK
    Ther Drug Monit; 1996 Dec; 18(6):693-7. PubMed ID: 8946667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
    vasBinder E; Annesley T
    Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR; Dhruv RA
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the autonomic effects of procainamide and N-acetylprocainamide in the dog.
    Reynolds RD; Gorczynski RJ
    J Pharmacol Exp Ther; 1980 Mar; 212(3):579-83. PubMed ID: 6153717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High performance liquid chromatographic method for determination of procainamide and its active metabolites, N-acetylprocainamide in serum].
    Zhang SQ; Olugo-Edege GC; Zhu YP; Mao FF; An DK
    Yao Xue Xue Bao; 1988 Jun; 23(6):430-4. PubMed ID: 2463733
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
    Kessler KM; Ho-Tung P; Steele B; Silver J; Pickoff A; Narayanan S; Myerburg RJ
    Clin Chem; 1982 May; 28(5):1187-90. PubMed ID: 6176367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme immunoassay, liquid chromatography, and spectrofluorometry compared for the determination of procainamide and N-acetylprocainamide in serum.
    Pape BE
    J Anal Toxicol; 1982; 6(1):44-8. PubMed ID: 6176781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.